3Newton JR. Cl&s.sification and comparison of oral contraceptives containing new generation progestogens. Hum Reprod Update,1995,1 (2) :231-263. 被引量：1
4Wailing M. A multicenter efficacy and safety study of an oral contraceptive containing 150μg desoge.strel and 30μg ethinyl strodiol.Contraception, 1992,46 ( 2 ) : 313-326. 被引量：1
5Crook D, Godsland IF, Worthinton M. A comparative metabolic study of two low -estrogen-dose oral contraceptives containing desgestrel or gestodene progestin. Am J Obstet Gynecol, 1993, 169(5) : 1183-1189. 被引量：1
6Crosiganani PC,, Finelli F, Pizzi C. Multieenter clinical trial on triphasic gestodene. In: Genazzani AR, Skouby SO(eds). Triphasic Gestodene- a new approch to oral contraception. 1992 Parthenon Publishing,Camforth. UK,77Corson SL. Efficacy and clinical profile of a new oral contraceptive containing norgestimate. Acta Obstet Gynecol Scand Suppl, 1990,152( 1 ) :25-31. 被引量：1
7London RS, Chapdelaine A, Upmalis D, et al. Comparative efficacy and mechanism of action of the norgestimate-containing triphasic oral contraceptive. Acta Obstet Gynecol Scand Suppl, 1992,156( 1 ) :9-14. 被引量：1
8Carr BR. Cycle control with desogestrel-containing oral contraceptive-comparison of a monophasic and tripha.sic regimen, lnt J Fertil,1993,38 ( 5 ) : 274-279. 被引量：1
9Brill K,Schnitker J ,Albring M. Long-term experience with a lowdose oral contraceptive. Clin Endocrinol, 1991,4(2) :277-286. 被引量：1
10Damey P. Safety and efficacy of a triphasic oral contraceptive containing desogestrel: results of three multlcenter trials. Contraception, 1993,48 (4) : 323-337. 被引量：1
